Glaucoma News

FDA Committee Backs Netarsudil, a Once-Daily Glaucoma Drug - Medscape



Medscape
 
FDA Committee Backs Netarsudil, a Once-Daily Glaucoma Drug 
Medscape
A first-in-its-class eye drop to reduce intraocular pressure (IOP) for patients with open-angle glaucoma or ocular hypertension drew high marks at an FDA advisory committee meeting on October 13. Aerie Pharmaceuticals representatives discussed ...
This Biotech Yo-Yos After FDA Panel Recommends Glaucoma Drug Investor's Business Daily
FDA experts give a thumbs-up to Aerie Pharma's glaucoma drug Endpoints News
Aerie Pharmaceuticals stock halted for FDA committee review of glaucoma treatment MarketWatch
Nasdaq  -Zacks Investment Research 
all 103 news articles » 


Presenter: 'Room for growth' for optometry in glaucoma care - Healio



Presenter: 'Room for growth' for optometry in glaucoma care 
Healio
CHICAGO ? Ophthalmologists submit a ?much higher percentage? of Medicare claims for glaucoma testing, according to Mark W. Swanson, OD, MSPH, FAAO, in a presentation here at the American Academy of Optometry meeting. At an academy-sponsored ...

 


The FDA's insider view on Aerie's glaucoma drug: Yes on efficacy, but? - Endpoints News



Investor's Business Daily
 
The FDA's insider view on Aerie's glaucoma drug: Yes on efficacy, but? 
Endpoints News
The FDA had some encouraging words for Aerie's new glaucoma drug Rhopressa, but there's a significant caveat that might come back to haunt the biotech as it hunts an approval. In the internal review offered up by the agency two days ahead of the ...
Aerie's glaucoma drug effectively lowers eye pressure: FDA review Reuters
Aerie Pharmaceuticals Stock Rocketed 19% After The FDA's ... Investor's Business Daily
FDA review says Aerie glaucoma drug effectively lowers eye pressure; shares jump Nasdaq
Smarter Analyst  -Zacks Investment Research  -SEC.gov  -SEC.gov 
all 132 news articles » 


Eyes on glaucoma - Star2.com



Star2.com
 
Eyes on glaucoma 
Star2.com
Glaucoma is becoming an increasingly prevalent cause of blindness as the world's population ages. Statistics gathered by the World Health Organization (WHO) in 2002 showed that glaucoma was the second leading cause of blindness globally, after ...

 


Glaucoma - Pipeline Review, H2 2017 - PR Newswire (press release)



Medgadget
 
Glaucoma - Pipeline Review, H2 2017 
PR Newswire (press release)
The exact cause of optic nerve damage from glaucoma is not fully understood, but involves mechanical compression and/or decreased blood flow of the optic nerve. The most important risk factors include age, elevated eye pressure, African ancestry, thin ...
Glaucoma (Ophthalmology) Pipeline Market Global Market Analysis, Growth, Share, Industry Trends and Forecasts Medgadget (blog)

all 32 news articles » 


For Medicare Patients, Optometrists Lag in Glaucoma Testing - MedPage Today



For Medicare Patients, Optometrists Lag in Glaucoma Testing 
MedPage Today
CHICAGO -- Ophthalmologists ordered and performed the overwhelming majority of glaucoma-related eye tests in the Medicare population, a disparity that could have major implications for the future of optometry, researchers said here. The review of five ...

 


Coming Soon: Glaucoma Self-Care, From Home? - WebMD



Coming Soon: Glaucoma Self-Care, From Home? 
WebMD
FRIDAY, Sept. 22, 2017 (HealthDay News) -- For many glaucoma patients, repeat trips to a doctor's office to check on their eyes can be a real pain. But new research supports the usefulness of a device that allows glaucoma patients to measure their own ...

and more » 


Engaging OCTA in glaucoma imaging - ModernMedicine



ModernMedicine
 
Engaging OCTA in glaucoma imaging 
ModernMedicine
Ophthalmologists could have a new tool to assess progression in glaucoma by measuring vascular damage in the retina and optical nerve head. Optical coherence tomography angiography (OCTA) can directly measure retinal vessel densities in a ...

 


Global Glaucoma Medications Market 2017: SANDOZ, Greenstone, Mylan, GE Medical - Digital Journal



Global Glaucoma Medications Market 2017: SANDOZ, Greenstone, Mylan, GE Medical 
Digital Journal
Firstly, Worldwide Glaucoma Medications Market report provides a basic overview of the Glaucoma Medications industry including classification, definitions, Key vendors, Growth Drivers, Competitive Landscape, Regional Analysis and Glaucoma Medications ...

 


Areas and factors associated with patients' dissatisfaction with glaucoma care - Dove Medical Press



Areas and factors associated with patients' dissatisfaction with glaucoma care 
Dove Medical Press
Methods: Patients, aged ?21 years, from a specialist glaucoma service in a tertiary eye hospital in Singapore for at least 6 months, were recruited for this cross-sectional study between March and June 2014. All consenting patients completed a 7-area ...